XOMA Royalty (XOMA) Long-Term Investments (2018 - 2022)
XOMA Royalty (XOMA) reported Long-Term Investments of $500000.0 for Q1 2022, down 37.5% on a YoY basis from $800000.0 in Q1 2021, and down 37.5% sequentially from $800000.0 in Q4 2021.
XOMA Royalty (XOMA) Long-Term Investments (2018 - 2022) Analysis & Trends
XOMA Royalty (XOMA) has 5 years of Long-Term Investments data on file, last reported at $500000.0 in Q1 2022.
- For the quarter ending Q1 2022, Long-Term Investments fell 37.5% year-over-year to $500000.0; the trailing twelve-month figure through Mar 2022 stood at $500000.0 (down 37.5% YoY), and the FY2021 full-year result was $800000.0, down 52.75% from the prior year.
- Long-Term Investments fell to $500000.0 in Q1 2022, from $800000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $2.6 million in Q3 2020 to a low of $347000.0 in Q3 2018.
- A 5-year average of $993437.5 and a median of $800000.0 in 2021 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments slumped 63.14% in 2020 and jumped 333.15% in 2021, its largest moves.
- Tracing XOMA's Long-Term Investments over 5 years: stood at $392000.0 in 2018, then soared by 73.72% to $681000.0 in 2019, then surged by 148.6% to $1.7 million in 2020, then slumped by 52.75% to $800000.0 in 2021, then sank by 37.5% to $500000.0 in 2022.
- Business Quant data shows XOMA's Long-Term Investments at $500000.0 in Q1 2022, $800000.0 in Q4 2021, and $1.2 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 2.30 Mn |
| Mar 31, 2021 | 800,000.00 |
| Dec 31, 2020 | 1.69 Mn |
| Sep 30, 2020 | 2.57 Mn |
| Jun 30, 2020 | 531,000.00 |
| Mar 31, 2020 | 408,000.00 |
| Dec 31, 2019 | 681,000.00 |
| Sep 30, 2019 | 873,000.00 |
| Jun 30, 2019 | 1.14 Mn |
| Mar 31, 2019 | 1.11 Mn |
| Dec 31, 2018 | 392,000.00 |
| Sep 30, 2018 | 347,000.00 |
| Jun 30, 2018 | 553,000.00 |